AGP
BNTX icon

Artia Global Partners’s BioNTech BNTX Stock Holding History

Artia Global Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37,108
Closed -$4.01M – 30
2023
Q2 		$4.01M Hold
37,108
– – 1.38% 21
2023
Q1 		$4.62M Hold
37,108
– – 1.71% 16
2022
Q4 		$5.57M Buy
+37,108
New +$5.71M 2.12% 11

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Artia Global Partners's BNTX Position: Q3 2023 in Review

Artia Global Partners sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 37,108 shares — an estimated $4.01M sold.

Artia Global Partners first reported a position in BNTX in Q4 2022 and held it in 3 quarters. The position peaked at $5.57M in Q4 2022. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

  • Artia Global Partners reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
  • Artia Global Partners sold 37,108 BioNTech shares in Q3 2023, an estimated $4.01M.
  • Artia Global Partners first reported a position in BioNTech in Q4 2022 and held it in 3 quarters.
  • Artia Global Partners's BioNTech position peaked at $5.57M in Q4 2022.
  • 252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Artia Global Partners's 13F filing for Q3 2023, filed 14 Nov 2023.